Chronic Disease Management Market Analysis

  • Report ID: 4242
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Chronic Disease Management Market Analysis

Disease Type (Cancer, Diabetes, Cardiovascular Diseases, Arthritis, Asthma, Chronic Obstructive Pulmonary Disorders (COPD), Stroke)

The cardiovascular diseases segment is estimated hold 30% share of the global chronic disease management market in the coming years owing to the growing prevalence of chronic illnesses in the world. Moreover, heart failure, coronary artery disease, stroke, and other illnesses that impact the blood vessels and the heart are all included in CVD. Blood pressure, high blood cholesterol, smoking, inactivity, a poor diet, and obesity are all CVD risk factors. A major amount of the global illness burden is attributable to CVD, which is one of the main causes of mortality worldwide.

According to the World Health Organization (WHO), the largest cause of mortality worldwide is cardiovascular disease (CVD), followed by cancer, respiratory conditions, and diabetes. Furthermore, more than 17 million people die every year owing to cardiovascular diseases around the world.

Type (Solutions, Services)

Chronic disease management market from the solutions segment is set to garner a notable share shortly on the back of increased awareness regarding the use of cloud-based healthcare solutions. The best option to enable patients to share health information for advancing the treatment of chronic diseases is determined to be a hybrid cloud solution as it enhances the environment for healthcare, enables remote monitoring, boosts operational effectiveness, and reduces costs. This can help in the management of chronic diseases more efficiently.

Our in-depth analysis of the global chronic disease management market includes the following segments:

   Type

  • Solutions
  • Services

   Deployment Mode

  • On-Premise
  •  Web-Based
  •  Cloud-Based

   Disease Type

  • Cancer, Diabetes
  •  Cardiovascular Diseases
  •  Arthritis
  •  Asthma
  •  Chronic Obstructive Pulmonary Disorders (COPD)
  • Stroke

   Service Type

  • Consulting Service
  •  Implementation Service
  • Educational Services

   End-User

  • Providers
  •  Payers
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4242
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of chronic disease management is assessed at USD 8.93 billion.

The chronic disease management market size was over USD 7.99 billion in 2024 and is expected to reach USD 46.56 billion by the end of 2037, growing at around 14.6% CAGR during the forecast period i.e., between 2025-2037. Increasing use of tobacco across the globe and the worldwide upsurge in chronic obstructive pulmonary disease (COPD) will boost the market growth.

North America industry is predicted to account for the largest share of 47% by 2037, impelled by increasing spending in healthcare in the region.

The major players in the market include WellSky Corporation, Cedar Gate Technologies, Pegasystems Inc., Koninklijke Philips N.V, Altruista Health, Cognizant TriZetto Software Group Inc, Infosys Limited, Hinduja Global Solutions Ltd., Epic Systems Corporation, NXGN Management.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample